Literature DB >> 26362423

Evaluation of Congenital Valvular Heart Diseases by the Pediatrician: When to Follow, When to Refer for Intervention?

Anil Kumar Singhi1, Raman Krishna Kumar2.   

Abstract

Isolated congenital valvular heart disease in children constitutes a small fraction of congenital heart diseases. Valve involvement is seen more along with other congenital diseases. The most commonly involved valve is the pulmonary valve followed by the aortic valve. Stenotic lesions of the pulmonary and aortic valves are more frequently encountered than mitral and tricuspid valvular lesions. The presentation depends on the severity of the lesion and the age of the patient. Symptoms range from asymptomatic status to florid symptoms of valve obstruction and/or leak. Detailed clinical assessment and various imaging techniques confirm the diagnosis and help in management planning. Transcatheter balloon dilatation for obstructive pulmonary valve has very good long-term outcomes. The results of balloon dilation of aortic valve are also good enough for it to be the treatment of choice. Significant lesions of the mitral and tricuspid valve, regurgitant lesions, sub and supra valvular obstructions require surgical correction. Most valvar lesions mandate regular follow up. Communication and coordination between the pediatric cardiologist and the pediatrician helps in the optimal management.

Entities:  

Keywords:  Catheter intervention; Congenital valvular disease; Follow-up

Mesh:

Year:  2015        PMID: 26362423     DOI: 10.1007/s12098-015-1870-8

Source DB:  PubMed          Journal:  Indian J Pediatr        ISSN: 0019-5456            Impact factor:   1.967


  17 in total

1.  CONGENITAL AORTIC STENOSIS SYNDROME IN INFANCY.

Authors:  A R HASTREITER; M OSHIMA; R A MILLER; M LEV; M H PAUL
Journal:  Circulation       Date:  1963-12       Impact factor: 29.690

Review 2.  Bicuspid aortic valve disease.

Authors:  Samuel C Siu; Candice K Silversides
Journal:  J Am Coll Cardiol       Date:  2010-06-22       Impact factor: 24.094

3.  Congenital heart disease in 56,109 births. Incidence and natural history.

Authors:  S C Mitchell; S B Korones; H W Berendes
Journal:  Circulation       Date:  1971-03       Impact factor: 29.690

4.  The congenitally bicuspid aortic valve. A study of 85 autopsy cases.

Authors:  W C Roberts
Journal:  Am J Cardiol       Date:  1970-07       Impact factor: 2.778

5.  Anatomic types of congenital mitral stenosis: report of 49 autopsy cases with consideration of diagnosis and surgical implications.

Authors:  R N Ruckman; R Van Praagh
Journal:  Am J Cardiol       Date:  1978-10       Impact factor: 2.778

6.  Clinical spectrum and long-term follow-up of isolated mitral valve prolapse in 119 children.

Authors:  G S Bisset; D C Schwartz; R A Meyer; F W James; S Kaplan
Journal:  Circulation       Date:  1980-08       Impact factor: 29.690

7.  Congenital heart disease among 815,569 children born between 1980 and 1990 and their 15-year survival: a prospective Bohemia survival study.

Authors:  M Samánek; M Vorísková
Journal:  Pediatr Cardiol       Date:  1999 Nov-Dec       Impact factor: 1.655

8.  Congenital heart disease in a cohort of 19,502 births with long-term follow-up.

Authors:  J I Hoffman; R Christianson
Journal:  Am J Cardiol       Date:  1978-10       Impact factor: 2.778

9.  Results of balloon valvuloplasty in the treatment of congenital valvar pulmonary stenosis in children.

Authors:  D A Kveselis; A P Rocchini; A R Snider; A Rosenthal; D C Crowley; M Dick
Journal:  Am J Cardiol       Date:  1985-09-15       Impact factor: 2.778

10.  Early and late results of reconstructive operation for congenital mitral regurgitation in pediatric age group.

Authors:  Y Okita; S Miki; K Kusuhara; Y Ueda; T Tahata; Y Tsukamoto; M Komeda; K Yamanaka; S Shiraishi; T Tamura
Journal:  J Thorac Cardiovasc Surg       Date:  1988-08       Impact factor: 5.209

View more
  1 in total

1.  Editorial: What Does the Pediatrician Needs to Know About Heart Defects in Children?

Authors:  P Syamasundar Rao
Journal:  Indian J Pediatr       Date:  2015-09-14       Impact factor: 1.967

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.